$3.21
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 310 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Country

US

CEO

Ms. Leslie Trigg

IPO date

2020

Employees

310

ISIN

US6901452069

Key stats

Open

$3.30

Volume

89.08K

Market cap

$60.27M

Prev. close

$3.21

Impl / hst vl

-

Open interest

$0.00

$3.20

Day’s Range

$3.38

$3.00

52W Range

$6.49

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
0.51
P/B
0.63
Current ratio
5.19
Debt / Equity
1.02
ROE
-62.25%
Gross margin
41.99%
Income growth
-5.24%
FCF growth
-24.50

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.82
The top 6 analysts forecasts that 12-month price may increase by 143.61%, with a low of $6.06 and a high of $10.50
$6.06
Low
$7.82
Avg
$10.50
High
Current price

Earnings

Q2 ‘26 revenue
$31.64M
Q2 ‘26 net income
-$17.98M
Revenue
Net income
Previous EPS
-$0.83
Estimate EPS
-$0.74
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply